Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 22.84 K181.79 K154.14 K152.93 K 511.7 K Research & development ———— — Operating income -22.84 K-181.79 K-154.14 K-152.93 K -511.7 K Non-Operating Income, Total —-785.26 K1.17 M1.16 M — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses —-785.26 K1.17 M1.16 M — Unusual income/expense ———— — Pretax income -22.84 K-967.04 K1.02 M1 M 1.03 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -22.84 K-967.04 K1.02 M1 M 1.03 M Discontinued operations ———— — Net income -22.84 K-967.04 K1.02 M1 M 1.03 M Dilution adjustment —2.92 M—1.03 M — Preferred dividends —989.88 K—1.03 M — Diluted net income available to common stockholders -22.84 K967.04 K-1.01 M1 M 938.26 K Basic earnings per share (Basic EPS) -0.01-0.070.150.07 — Diluted earnings per share (Diluted EPS) -0.01-0.070.150.07 0.38 Average basic shares outstanding 3.33 M3.21 M5.31 M11.5 M — Diluted shares outstanding 3.33 M3.21 M5.31 M11.5 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —